The Symtomax Group and its subsidiaries are essentially structured to ensure a commitment to their values and to contribute to sustainable earnings and growth, whilst providing the best health solutions in organically produced medical cannabis oil to the healthcare sector. We have aligned the governance of our group with our strategic choices and our business model, and have ensured that this structure supports effective decision-making and individual accountability. Our group’s experience with cultivating cannabis, CBD products and alternative healthcare means that we have a valuable understanding of what is needed to successfully navigate complex and evolving regulations, earning a reputation for quality, integrity and responsibility.
News 
Market Data 
Discover 
